Stimufend Injection, Solution
Product Images NDC 72603-402

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Stimufend (NDC 72603-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Sti0a 0000 01)

An instructional diagram showing parts of a STIMUFEND (pegfilgrastim-fpgk) injection syringe. Labeled components include the gray needle cap, syringe barrel containing the medicine, needle safety guard (unactivated), finger grips, and plunger rod. The image aims to identify key features prior to use.*

FDA Label Image

Figure B (Sti0a 0000 02)

Illustration showing parts of a STIMUFEND 6 mg/.6 mL subcutaneous injection syringe, including the gray needle cap, clear needle guard, needle, used plunger rod, and needle safety guard positioned for safe disposal after injection.*

FDA Label Image

Figure C (Sti0a 0000 03)

An instructional illustration showing a hand holding a STIMUFEND 6 mg/0.6 mL prefilled syringe for subcutaneous injection. The image demonstrates preparation steps, including removing the syringe cap by pulling it upward, as part of the injection process for pegfilgrastim-fpgk solution by NorthStar Rx LLC.*

FDA Label Image

Figure D (Sti0a 0000 04)

An instructional illustration depicting two syringes side by side, with a red X mark over the left syringe and a green check mark over the right syringe, indicating the correct method or preferred syringe appearance for administration of STIMUFEND 6 mg/.6mL subcutaneous injection solution by NORTHSTAR RX LLC.*

FDA Label Image

Figure E (Sti0a 0000 05)

Illustration showing a syringe prepared for subcutaneous injection with labeled parts including the gray needle cap, medicine inside the syringe, and a visible label displaying expiration date details.*

FDA Label Image

Figure F (Sti0a 0000 06)

Illustration depicting components associated with the STIMUFEND 6 mg/.6 mL injection, solution for subcutaneous use by Northstar Rx LLC. The image shows a prefilled syringe, several cotton balls, a bandage, a medical wipe, and a red sharps disposal container, suggesting a typical injection procedure setup.*

FDA Label Image

Figures G And H (Sti0a 0000 07)

An anatomical illustration showing recommended subcutaneous injection sites for STIMUFEND (pegfilgrastim-fpgk) injection solution in a human figure. Injection areas labeled include the stomach area (abdomen), thigh, back area of upper arm, and upper outer area of the buttocks.*

FDA Label Image

Figure I (Sti0a 0000 08)

An instructional illustration showing a hand holding a syringe at a 45-degree angle to the forearm, indicating an injection being administered subcutaneously.*

FDA Label Image

Figure J (Sti0a 0000 09)

An instructional diagram showing a hand using a syringe to withdraw medication from a vial labeled STIMUFEND. The image includes a blue upward arrow indicating the motion of pulling the syringe plunger to draw the solution from the vial.*

FDA Label Image

Figure K (Sti0a 0000 10)

An instructional illustration labeled 'Figure K' showing a hand pressing down on a child-resistant safety cap to open a red container or vial, with a blue downward arrow indicating the pressing direction. The image demonstrates how to open the container.*

FDA Label Image

Figure L (Sti0a 0000 11)

An instructional illustration labeled 'Figure L' showing a hand pinching the skin on the upper arm to demonstrate the subcutaneous injection technique. Two blue arrows indicate the direction for proper needle insertion angle into the skin fold.*

FDA Label Image

Figure M (Sti0a 0000 12)

An instructional illustration showing the method for subcutaneous injection administration. The image depicts a hand holding a syringe angled between 45 and 90 degrees above the skin surface, demonstrating proper needle insertion technique.*

FDA Label Image

Figures N And O (Sti0a 0000 13)

An instructional illustration depicting the use of an injection device. Figure N shows a hand holding the device for subcutaneous injection at a finger site. Figure O provides a close-up of the injection device, highlighting the insertion or activation step.*

FDA Label Image

Figure P (Sti0a 0000 14)

An instructional illustration showing a hand holding a pen-like device positioned against a forearm. The image includes an arrow indicating the direction for injecting or administering the solution subcutaneously. It visually demonstrates the use of the injection device for administering STIMUFEND (pegfilgrastim-fpgk) 6 mg/0.6 mL injection, solution.*

FDA Label Image

Figure Q (Sti0a 0000 15)

An instructional illustration showing a hand holding a prefilled syringe designed for subcutaneous injection. The syringe is being capped or uncapped, with a red sharps disposal container partially visible below, indicating safe disposal practices for used syringes.*

FDA Label Image

Figure R (Sti0a 0000 16)

An illustration labeled as Figure R showing a hand applying pressure to a round adhesive patch on skin, likely demonstrating application or removal technique.*

FDA Label Image

Package Label – Principal Display – Stimufend –one 0.6 mL Single-dose (Sti0a 0000 17)

Packaging label for Stimufend (pegfilgrastim-fpgk) Injection 6 mg/0.6 mL, a single-dose pre-filled syringe for subcutaneous use. The label includes dosing information, storage instructions to refrigerate between 36°F to 46°F, and warnings about the syringe seal. Manufactured by Northstar RX LLC, the product contains pegylated recombinant methionyl human granulocyte colony-stimulating factor (PEG-rmetHuG-CSF) derived from E. coli. The label also notes the product contains dry natural rubber sterile solution with no preservative.*

FDA Label Image

Package Label – Principal Display – Stimufend – 0.6 mL Single-dose (Sti0a 0000 18)

Label for STIMUFEND injection, containing pegfilgrastim-fpgk, 6 mg/0.6 mL. The label identifies it as a pegylated recombinant methionyl human granulocyte colony-stimulating factor for subcutaneous use only. It is packaged as a single-dose pre-filled syringe. Manufactured by Fresenius Kabi USA, LLC and labeled by Northstar Rx LLC.*

FDA Label Image

Package Label – Principal Display – Stimufend – 0.6 mL Single-dose (Sti0a 0000 19)

Label for Stimufend injection solution contains pegfilgrastim-fpgk at a strength of 6 mg per 0.6 mL. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, and made for Northstar Rx LLC, Memphis, Tennessee. The label includes a barcode, lot number placeholder, and expiration date placeholder.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.